Phospho-GAB2 (Y643) Antibody

What is the significance of GAB2 Y643 phosphorylation in cell signaling pathways?

Phosphorylation of GAB2 at tyrosine 643 represents a critical regulatory event in multiple signaling cascades. GAB2 functions as an adapter protein acting downstream of several membrane receptors including cytokine, antigen, hormone, cell matrix, and growth factor receptors to regulate multiple signaling pathways . Y643 phosphorylation specifically:

• Creates a binding site for the SH2 domain of SHP2 phosphatase

• Is involved in ERK1/2 activation pathways

• Shows dynamic changes following growth factor stimulation (e.g., EGF, IFN)

• Forms part of the bisphosphotyrosine-containing motif (Y614/Y643) that relieves SHP2 autoinhibition

Methodologically, studying Y643 phosphorylation typically involves stimulating cells with appropriate growth factors or cytokines (10 nM EGF or 2500 U/ml IFN are commonly used concentrations), followed by detection using phospho-specific antibodies in time-course experiments.

How does SHP2 inhibition affect GAB2 Y643 phosphorylation?

SHP2 inhibition has a pronounced effect on GAB2 Y643 phosphorylation levels. Time-resolved phosphoproteomics reveals that:

• Y643 of GAB2 shows dramatic reduction in phosphorylation (pY) abundance upon SHP099 (SHP2 inhibitor) treatment

• pY marks recover following inhibitor washout

• This suggests that SHP2 actively protects Y643 from dephosphorylation by other phosphatases

In experimental settings, researchers typically treat cells with 10 μM SHP099 for 2 hours prior to growth factor stimulation. Western blot analysis with phospho-specific antibodies targeting GAB2-pY643 shows significant reduction in signal intensity following SHP2 inhibition . This phenomenon has been observed across multiple cell lines including MDA-MB-468 and U2OS cells.

What are the recommended applications for Phospho-GAB2 (Y643) antibodies?

Phospho-GAB2 (Y643) antibodies are validated for multiple research applications with specific recommended dilutions:

For optimal results:

• Perform antibody validation using appropriate positive controls (e.g., IFN-stimulated Jurkat cells)

• Include phospho-peptide blocking controls to confirm specificity

• Store antibodies at -20°C and avoid repeated freeze-thaw cycles

How do different SHP2 domains contribute to the protection of GAB2 Y643 phosphorylation?

Research utilizing domain-specific SHP2 constructs has revealed distinct roles for SHP2 domains in protecting GAB2 Y643 phosphorylation:

• The SH2 fragment of SHP2, but not the PTP (phosphatase) fragment, actively increases pY abundance at GAB2 Y643

• This protection occurs even in the absence of growth factor stimulation

• Point mutations of key arginine residues in SH2 domains (R32M of N-SH2 domain or R138M of C-SH2 domain) suppress phosphosite protection

• The SHP099-resistant variant of SHP2 (T253M/Q257L) rescues protection of GAB2 pY643 sites

These findings demonstrate that the catalytic activity of SHP2 is not required for protecting Y643 phosphorylation. Instead, the tandem SH2 domains of SHP2 bind to and physically shield pY643 from other cellular phosphatases. This mechanism represents a non-enzymatic function of SHP2 in signaling regulation.

How does GAB2 Y643 phosphorylation differ from other GAB2 phosphosites in response to kinase inhibitors?

Comparative phosphoproteomics analyses reveal site-specific responses of GAB2 phosphorylation to various kinase inhibitors:

This differential sensitivity pattern suggests that Y643 phosphorylation is regulated by kinases not targeted by these inhibitors. In contrast to other tyrosine phosphorylation sites on GAB2, Y643 phosphorylation appears to be more resilient to these commonly used TKIs in CML treatment . This has important implications for understanding GAB2 signaling persistence following treatment with these inhibitors.

What experimental approaches can resolve contradictory data regarding GAB2 Y643 phosphorylation?

Researchers sometimes encounter contradictory results regarding GAB2 Y643 phosphorylation. A systematic troubleshooting approach includes:

• Antibody validation:

  • Confirm antibody specificity using phospho-peptide blocking controls

  • Compare results across multiple antibody clones/vendors

  • Use genetically modified cell lines (Y643F mutants) as negative controls

• Cell type considerations:

  • H1975 cells (with EGFR activating mutation) display high constitutive GAB2-Y643 phosphorylation

  • Jurkat cells show robust IFN-induced Y643 phosphorylation

  • Different cell lines may exhibit different baseline and stimulated phosphorylation dynamics

• Time-resolved analysis:

  • Implement comprehensive time-course experiments (0-120 min)

  • Use both Western blotting and mass spectrometry-based approaches

  • Quantitative phosphoproteomics with SILAC labeling can provide more precise quantification

• Multiple detection methods:

  • Compare results from phospho-specific antibodies with mass spectrometry data

  • Consider using Phos-tag SDS-PAGE for enhanced separation of phosphorylated species

  • Proximity ligation assays can confirm protein-protein interactions dependent on Y643 phosphorylation

How can Phospho-GAB2 (Y643) Antibody be used to investigate SFK-mediated phosphorylation of GAB2?

Multiple studies have reported that GAB2 can be phosphorylated by Src family kinases (SFKs). A comprehensive experimental approach to investigate this includes:

• SFK inhibition studies:

  • Treat cells with SFK inhibitors (e.g., saracatinib/AZD0530)

  • Monitor GAB2-Y643 phosphorylation by Western blotting

  • Research shows greatly reduced modification of GAB2-Y643 following SFK inhibition

• Kinase assays:

  • Perform in vitro kinase assays using recombinant SFKs and GAB2 substrates

  • Use synthetic peptides spanning the Y643 region (amino acids 609-658)

  • Quantify phosphate incorporation using phospho-specific antibodies or radioactive ATP

• Genetic approaches:

  • Express constitutively active or dominant-negative SFK mutants

  • Use CRISPR/Cas9 to generate SFK knockout cell lines

  • Rescue experiments with individual SFK family members can identify the specific kinase responsible

• Temporal dynamics:

  • Compare the kinetics of SFK activation (pY416) with GAB2-Y643 phosphorylation

  • Determine if GAB2-Y643 phosphorylation precedes or follows SHP2 recruitment

This methodological framework allows researchers to establish the causal relationship between SFK activity and GAB2-Y643 phosphorylation in various signaling contexts.

What is the relationship between GAB2 Y643 phosphorylation and other post-translational modifications on GAB2?

GAB2 undergoes complex patterns of post-translational modifications that exhibit cross-regulation. Analysis of the relationship between Y643 phosphorylation and other modifications reveals:

• Serine/Threonine phosphorylation:

  • Akt-mediated phosphorylation of S159 inhibits GAB2 tyrosine phosphorylation and downstream signal amplification

  • S210 and T391 phosphorylation leads to 14-3-3 protein recruitment, which can sterically hinder access to tyrosine residues

  • Mutation of S210 and T391 to alanine (GAB2 2×A) enhances GAB2 signaling potential

• Multi-site tyrosine phosphorylation:

  • Y643 forms part of a bisphosphotyrosine motif with Y614

  • Both sites are required for optimal SHP2 binding and activation

  • Mass spectrometry analysis identified at least 72 phosphorylation sites on GAB2, suggesting complex regulatory networks

• Temporal regulation:

  • Different phosphorylation events follow distinct kinetics

  • Y643 phosphorylation typically occurs rapidly following receptor activation (within 5 minutes)

  • Inhibitory serine phosphorylation often serves as negative feedback with delayed kinetics

The methodological approach to study these relationships includes site-directed mutagenesis (creating single and combination mutants), phospho-specific antibody arrays, and quantitative mass spectrometry with enrichment for phosphopeptides.

How should researchers interpret changes in GAB2 Y643 phosphorylation in the context of cellular signaling network perturbations?

Interpreting changes in GAB2 Y643 phosphorylation requires a systems biology perspective that considers:

• Network context:

  • GAB2 functions as a signaling hub connecting multiple upstream receptors to downstream pathways

  • Y643 phosphorylation should be analyzed alongside other signaling nodes (e.g., ERK, AKT, STAT)

  • Changes may reflect pathway rewiring rather than direct effects on GAB2

• Temporal dynamics:

  • Time-resolved phosphoproteomics reveals three distinct patterns of response to SHP2 inhibition :
    a) Early substrate-like responses
    b) Late substrate-like responses
    c) Rebound patterns (like Y643)

  • These patterns help classify direct versus indirect effects

• Quantitative considerations:

  • Partial versus complete loss of phosphorylation may have different biological meanings

  • Threshold effects often determine biological outcomes

  • Relative changes compared to baseline are often more informative than absolute values

• Functional validation:

  • Correlate Y643 phosphorylation changes with downstream biological responses

  • Use GAB2 Y643F mutants to establish causality rather than correlation

  • Employ cellular phenotypic assays (proliferation, migration, differentiation) to establish functional significance

What are the best experimental controls for validating the specificity of Phospho-GAB2 (Y643) Antibody detection?

Rigorous validation of phospho-specific antibodies requires multiple controls:

• Peptide competition assays:

  • Pre-incubate antibody with phosphorylated peptide containing the Y643 epitope

  • This should abolish the signal in Western blot or immunohistochemistry

  • Non-phosphorylated peptide should not compete for binding

• Genetic controls:

  • Generate Y643F mutant (cannot be phosphorylated)

  • Use GAB2 knockout cells as negative controls

  • Rescue experiments with wild-type versus Y643F GAB2 confirm specificity

• Treatment controls:

  • Use phosphatase treatment of lysates to eliminate phospho-epitopes

  • Lambda phosphatase is commonly used for this purpose

  • Signal should be abolished following phosphatase treatment

• Stimulation gradients:

  • Include both untreated and maximally stimulated samples

  • For GAB2 Y643, IFN treatment (2500 U/ML, 30 mins) of Jurkat cells serves as a positive control

  • Dose-response curves can further validate antibody specificity

• Cross-validation with multiple detection methods:

  • Compare results from antibody-based methods with mass spectrometry

  • Use phospho-enrichment techniques (IMAC, TiO2) prior to mass spectrometry

  • Phos-tag SDS-PAGE provides an antibody-independent method to detect phosphorylated proteins

How can researchers optimize Western blot protocols for detecting GAB2 Y643 phosphorylation in different cell types?

Optimizing Western blot protocols for phospho-GAB2 (Y643) detection requires consideration of several factors:

• Sample preparation:

  • Rapid lysis is critical to preserve phosphorylation status

  • Include phosphatase inhibitors (sodium orthovanadate, sodium fluoride, β-glycerophosphate)

  • Maintain samples at 4°C throughout processing

• Cell type-specific considerations:

  Cell Type	Optimal Stimulation	Lysis Buffer	Recommended Antibody Dilution
  MDA-MB-468	EGF (10 nM)	RIPA with phosphatase inhibitors	1:1000
  Jurkat	IFN (2500 U/mL)	NP-40 with phosphatase inhibitors	1:500
  K562	No stimulation needed (constitutive)	RIPA with phosphatase inhibitors	1:1000

• Gel separation:

  • Use 7.5% acrylamide gels for optimal separation of GAB2 (98 kDa)

  • Consider Phos-tag™ acrylamide for enhanced phospho-protein separation

  • Extended run times improve separation of phosphorylated from non-phosphorylated species

• Transfer and blocking:

  • Wet transfer at 30V overnight improves transfer of large proteins

  • Block with 5% BSA (not milk) in TBST to prevent phosphatase activity

  • Use phospho-protein friendly PVDF membranes

• Detection optimization:

  • Primary antibody incubation overnight at 4°C improves sensitivity

  • Use phospho-enhanced ECL substrates for detection

  • Consider fluorescent secondary antibodies for more quantitative analysis

• Controls and normalization:

  • Always include total GAB2 detection on parallel blots or after stripping

  • Normalize phospho-signal to total protein rather than housekeeping proteins

  • Include positive control lysates (IFN-stimulated Jurkat cells) across blots

What mass spectrometry approaches are most effective for analyzing GAB2 Y643 phosphorylation in complex samples?

Mass spectrometry offers powerful approaches for analyzing GAB2 phosphorylation:

• Sample preparation strategies:

  • Immunoprecipitate GAB2 prior to MS analysis to enrich the target protein

  • Phosphopeptide enrichment using IMAC or TiO2 significantly improves detection

  • Tryptic digestion generates peptides containing Y643 in the range of 609-658 aa

• Quantitative MS approaches:

  • SILAC labeling enables direct comparison between conditions

  • TMT labeling allows multiplexing of up to 11 samples

  • Label-free quantification can be used when metabolic labeling is not feasible

• MS/MS fragmentation:

  • Higher-energy collisional dissociation (HCD) provides better phosphotyrosine fragment detection

  • Electron transfer dissociation (ETD) preserves labile phosphorylations

  • LC-MS3 mass spectrometry improves specificity for phosphopeptides

• Data analysis considerations:

  • Search for Y643-containing peptides in multiple charge states

  • Account for potential missed cleavages around phosphorylation sites

  • Consider the possibility of multiple phosphorylations on the same peptide

• Validation of MS findings:

  • Confirm key findings with synthetic phosphopeptide standards

  • Cross-validate with antibody-based methods

  • Perform targeted MS assays (PRM/MRM) for improved sensitivity

In one study, TMT signal-to-noise intensities of GAB2 pY643 peptides showed dynamic changes in phosphorylation under DMSO- and SHP099-treated conditions, providing quantitative data on inhibitor effects .

How should researchers approach the temporal dynamics of GAB2 Y643 phosphorylation in response to growth factor stimulation?

Capturing the temporal dynamics of GAB2 Y643 phosphorylation requires careful experimental design:

• Time course design:

  • Include early time points (0, 2, 5, 10 min) to capture initial phosphorylation events

  • Include later time points (30, 60, 120 min) to capture feedback regulation

  • Consider using automated liquid handling systems for precise timing

• Stimulus considerations:

  • EGF (10 nM) typically induces rapid GAB2 Y643 phosphorylation

  • IFN (2500 U/mL) provides strong GAB2 Y643 phosphorylation in certain cell types

  • Pre-treatment with inhibitors should be performed 1-2 hours before stimulation

• Quantitative analysis methods:

  • Western blotting with phospho-specific antibodies

  • Quantitative phosphoproteomics with time-resolved sampling

  • Single-cell approaches (phospho-flow cytometry) for heterogeneity assessment

• Integrated pathway analysis:

  • Monitor upstream kinase activation simultaneously (e.g., SFK pY416)

  • Track downstream signaling events (ERK1/2 phosphorylation)

  • Mathematical modeling can help infer causality from correlation

• Perturbation approaches:

  • Use rapid inhibitor addition/washout experiments

  • Temperature-sensitive kinase mutants allow precise temporal control

  • Optogenetic approaches enable spatiotemporal control of signaling

Research has shown that Y643 phosphorylation typically follows receptor activation within minutes, reaches maximum levels by 5-10 minutes, and can persist for over an hour depending on the cellular context and stimulus .

By applying these methodological approaches, researchers can effectively investigate the complex regulation and functional significance of GAB2 Y643 phosphorylation in diverse biological contexts.